Clinical Trial Update: Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz [Phase 2]

View source ↗

Summary

Phase 2 trial update on therapeutic drug monitoring for a generic three-drug regimen (tenofovir/emtricitabine/efavirenz) in HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• tenofovir/emtricitabine/efavirenz (tenofovir disoproxil fumarate/emtricitabine/efavirenz)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV | Phase 2 | Status: COMPLETED